Innovative Technology in Sildenafil Cream Developed for WomenSildenafil
ViagraDiscover the innovative "black technologies" used in the development of sildenafil cream for women. Learn about the KNOSISTM local drug delivery system and its clinical trials for improving female sexual arousal disorder (FSAD) while minimizing side effects.
Vitiligo - The Hundred Billion Blue OceanVitiligoVitiligo, a global skin condition affecting millions, remains an urgent medical challenge with no definitive cure. Explore the latest advances in treatment, including JAK inhibitors and stem cell therapies, and the promising future of vitiligo care.
HELENE Clinic MSC Study ResultsHELENEHELENE Clinic in Tokyo confirms the safety of high-dose autologous MSC infusions (up to 2 billion cells) in a study of 2,504 patients. The results highlight MSC's efficacy in anti-aging and cardiovascular health with a strong safety record.
Tecovirimat Ineffective for Clade I Mpox in DRC StudyNIHA recent NIH study in the Democratic Republic of the Congo found that tecovirimat does not improve clade I mpox lesion resolution. Despite this, mortality rates were lower than average. The study emphasizes the need for more research on effective treatments and vaccines for clade I mpox.
Study Reveals Distinct Long COVID Patterns in Youth: Insights from NIH ResearchNIHAn NIH-supported study published in JAMA uncovers unique long COVID symptom patterns in school-age children and adolescents. The research highlights 18 symptoms in younger children and 17 in adolescents, with significant age-specific differences.
FDA Approves Durvalumab for Neoadjuvant NSCLC TreatmentFDA
AstraZenecaThe FDA has approved durvalumab (Imfinzi) for use with platinum-based chemotherapy as neoadjuvant treatment for resectable non-small cell lung cancer (NSCLC). The regimen, followed by adjuvant durvalumab post-surgery, shows improvement in event-free survival and pathological complete response.
Cabotegravir Safe for HIV Prevention in PregnancyNIHNIH confirms long-acting cabotegravir (CAB-LA) is safe for HIV prevention during pregnancy. The study, with over 300 pregnancies, shows similar maternal and infant outcomes.
New Target Identified for Dry AMD TreatmentNIHNIH and Johns Hopkins researchers uncover AKT2's role in dry AMD. Their study reveals that lysosomal dysfunction linked to AKT2 may pave the way for new treatments.
